Market Cap : 5.6 B | Enterprise Value : 9.26 B | PE Ratio : At Loss | PB Ratio : 1.15 |
---|
NYSE:PRGO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:PRGO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2022-08-15), Perrigo Co's 12-1 Month Momentum % is 1.31%.
The industry rank for Perrigo Co's 12-1 Month Momentum % or its related term are showing as below:
PRGO's 12-1 Month Momentum % is ranked better thanFor the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Perrigo Co's 12-1 Month Momentum % falls into.
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum % | = | ( Price 1-month ago | / | Price 12-month ago | - 1 ) | * | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Thank you for viewing the detailed overview of Perrigo Co's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Ives Alison | officer: EVP & Chief Scientific Officer | C/O PERRIGO COMPANY PLC 515 EASTERN AVENUE ALLEGAN MI 49010 |
Hanson Kyle | officer: EVP & General Counsel | |
Bezerra Eduardo Guarita | officer: EVP & Chief Financial Officer | C/O FRESH DEL MONTE PRODUCE INC. PO BOX 149222 CORAL GABLES FL 33134 |
Ashford Orlando D | director | C/O AMERANT BANK 220 ALHAMBRA CR. CORAL GABLES FL 33134 |
Doyle Katherine C. | director | 100 ABBOTT PARK ROAD, AP6C-1N D032L ABBOTT PARK IL 60064 |
Sorota Richard S | officer: EVP & President CSCA | HARMAN INTERNATIONAL INDUSTRIES, INC. 1101 PENNSYLVANIA AVE, NW, #1010 WASHINGTON DC 20004 |
Mann Erica L | director | ONE KELLOGG SQUARE P.O. BOX 3599 BATTLE CREEK MI 49016-3599 |
Silcock Raymond | officer: EVP, Chief Financial Officer | 399 JEFFERSON ROAD PARSIPPANY NJ 07054 |
Willis Robert | officer: Acting CHRO | C/O PERRIGO COMPANY PLC 515 EASTERN AVENUE ALLEGAN MI 49010 |
Dillard James E Iii | officer: EVP, Chief Scientific Officer | 6601 WEST BROAD STREET RICHMOND VA 23230 |
Kessler Murray S | director, officer: CEO | 714 GREEN VALLEY ROAD GREENSBORO NC 27408 |
Smith Jeffrey C | director | 777 THIRD AVENUE, 18TH FLOOR NEW YORK NY 10017 |
Roehrhoff Uwe | director, officer: CEO | C/O PERRIGO COMPANY PLC TREASURY BUILDING, LOWER GRAND CANAL ST DUBLIN L2 D2 |
Classon Rolf A | director | C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 |
Karaboutis Adriana | director | C/O BIOGEN IDEC INC. 225 BINNEY ST. CAMBRIDGE MA 02142 |
From GuruFocus
By PRNewswire 02-16-2022
By PRNewswire 08-03-2021
By PRNewswire 04-04-2022
Other Sources
By Zacks 2021-10-27
By Seekingalpha 2021-11-10
By Zacks 2021-12-07
By Zacks 2022-02-28
By Fool 2021-11-10
By Fool 2022-03-01
By Seekingalpha 2021-12-16
By Zacks 2022-02-08
By Seekingalpha 2022-01-09
By Zacks 2022-02-10
By Zacks 2022-02-15
By Zacks 2021-11-10
By Zacks 2022-03-01
By Seekingalpha 2022-03-01